Advertisement

Biomedical Microdevices

, Volume 3, Issue 2, pp 89–96 | Cite as

Bioadhesive Microdevices for Drug Delivery: A Feasibility Study

  • Aamer Ahmed
  • Chris Bonner
  • Tejal A. Desai
Article

Abstract

A variety of delivery systems have been devised to improve the oral bioavailability of drugs including enterically coated tablets, capsules, particles, liposomes, and others. Microfabrication technology, however, may offer some potential advantages over conventional drug delivery technologies. This technology, combined with appropriate surface chemistry, may permit the highly localized and unidirectional release of drugs, permeation enhancers, and/or promoters. In this study, we demonstrate the fabrication of prototype reservoir containing microparticles and a surface chemistry protocol that can be used to bind lectin via avidin-biotin interactions to silicon microparticles. In vitro studies show enhanced bioadhesion of these lectin conjugated microparticles. Such an approach can be used to improve the absorption of pharmacologically active biopolymers such as peptides, proteins and oligonucleotides into circulation at targeted sights in the GI system. Moreover, the use of microfabrication allows one to tailor the size, shape, reservoir volume, and surface characteristics of the drug delivery vehicle.

oral drug delivery microfabricated silicon lectin microparticles 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. Chen, V. Torchilin, and R. Langer, Pharm. Res. 13, 1378-1383 (1996).Google Scholar
  2. M.A. Clark, M.A. Jepson, and B.H. Hirst, Histochem. Cell. Biol. 104, 161-168 (1995).Google Scholar
  3. A. Fasano, Trends Biotech. 16, 152-157 (1998).Google Scholar
  4. F. Gabor, M. Stangl, and M. Wirth, J. Controlled Rel. 55, 131-142 (1998).Google Scholar
  5. P.J. Giannasca, K.T. Giannasca, P. Falk, J.I. Gordon, and M.R. Neutra, Am. J. Physiol. 276, G1108-G1121 (1994).Google Scholar
  6. N. Hussain, P.U. Jani, and A.T. Florence, Pharm. Res. 14, 613-618 (1997).Google Scholar
  7. J.M. Irrache, C. Durrer, D. Duchene, and G. Ponchel, Pharm. Res. 13, 1716-1719 (1996).Google Scholar
  8. B. Naisbett and J. Woodley, Int. J. Pharm. 107, 223-230 (1994a).Google Scholar
  9. B. Naisbett and J. Woodley, Int. J. Pharm. 110, 127-136 (1994b).Google Scholar
  10. H. Nashat, M. Moronne, and M. Ferrai, Biotech. Bioeng. 60, 137-146 (1998).Google Scholar
  11. P. Ponchel and J.-M. Irache, Adv. Drug Del. Rev. 34, 191-219 (1998).Google Scholar
  12. K.J. Sultzbaugh and T.J. Speaker, J. Microencapsul. 13, 363-375 (1996).Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Aamer Ahmed
    • 1
  • Chris Bonner
    • 1
  • Tejal A. Desai
    • 1
  1. 1.Department of BioengineeringUniversity of IllinoisChicagoUSA

Personalised recommendations